Tesamorelin

What this compound is

Tesamorelin in supply terms

Tesamorelin is a modified 44-amino-acid analogue of growth hormone releasing hormone (GHRH), giving it a molecular formula of C221H366N72O67S and a molecular weight of approximately 5135.9 g/mol. At 44 residues it is substantially larger than the shorter GHRH-derived fragments elsewhere in this range, such as CJC-1295, and its weight reflects the full-length modified sequence rather than a truncated fragment. The GHRH classification groups Tesamorelin with CJC-1295 No DAC and CJC-1295 with DAC on the catalogue's specification pages, but the three are chemically distinct entries: different sequence lengths, different formulas and different molecular weights, each listed under its own catalogue entry and Certificate of Analysis. Buyers sourcing across this sub-category should regard the shared classification as a filing convention rather than an indication that the items are interchangeable. Tesamorelin is supplied as a white to off-white lyophilised powder, listed at a 5mg dosage strength, typically reconstituted using bacteriostatic water or sterile laboratory-grade water. Store refrigerated at 2-8C in a cool, dry environment away from direct sunlight; long-term storage prior to reconstitution may require freezing conditions. The common research format is lyophilised powder in multi-dose vials for injectable research use.

This section describes the compound as a material. It makes no claim about any effect and is not guidance on use.